As previously reported, BofA analyst Jason Gerberry upgraded United Therapeutics (UTHR) to Neutral from Underperform with an unchanged price ...

BofA upgraded United Therapeutics (UTHR) to Neutral from Underperform with a $314 price target Stay Ahead of the Market: Discover ...

D.C.-area manufacturers produce a surprising array of goods, from microchips to coffee — though they don't always make it here.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

March 25, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics ®, Inc. (Nasdaq ... it will present data at the National Kidney Foundation Spring Clinical Meetings 2025 (NKF SCM25), which will take ...

announced today that the management team will participate in the Piper Sandler Spring Biopharma Symposium in Boston. The Aquestive team will host investor meetings at the event on April 17. About ...

They are seeking safety and the chance to move their lives forward. Why are refugees arriving in Silver Spring? The United States has a long tradition of sheltering those fleeing conflict and ...

Here's why it's re-investing now. Central, a 243-unit multifamily building in downtown Silver Spring, has a new Florida-based owner. Galium Capital, a Miami private equity firm, paid $71.35 ...

It is worth considering United Therapeutics (UTHR), which belongs to the Zacks Medical - Drugs industry. This drugmaker has an established record of topping earnings estimates, especially when ...

Ishatta King and Halal Gebrewolde are two members of the team at Springbrook High School in Silver Spring; hard at work figuring out how to send a payload into space. Inside a tiny box ...